SEC Form 3 · accession 0001354488-16-007882
Cellular Biomedicine Group, Inc. · CBMG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dangdal International Group Co. Ltd
10% Owner
Period of report
Feb 4, 2016
Accepted (ET)
Jun 23, 2016 · 11:09 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001378624
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 2,270,000 | D |
Table II — derivative securities
No Table II lines on this filing.